Skip to main content
. 2018 May 18;19(5):1510. doi: 10.3390/ijms19051510

Table 2.

Novel TP53 somatic mutations identified by NGS in six patients with HGSOC.

Case ID Exon Genomic Coordinate Alt Ref Read Depth Alt Read Depth cDNA Nucleotide Change AA Change Mutation Type
(%) a
305 7 17:7,577,541 58.43 15,734 9194 c.728_739delTGGGCGGCATGA p.Met243_Met247del In-frame
INDEL
519 8 17:7,577,128 47.84 6377 3051 c.795_809delGGGACGGAACAGCTT p.Gly266_Phe270del In-frame
INDEL
627 8 17:7,577,111 22.34 4692 1048 c.826_827GC>AT p.Ala276Ile Missense
738 10 17:7,574,004 53.41 4606 2460 c.1022insT p.Arg342Profs*5 Frameshift
INDEL
751 11 17:7,572,928 8.32 2994 249 c.1180delT p.Ter394Aspfs*28 Frameshift
INDEL
761 6 17:7,578,275 73.38 7205 5287 c.573insT p.Gln192Serfs*17 Frameshift
INDEL

a Alternative allele frequency; NGS: next-generation sequencing; HGSOC: high-grade serous ovarian cancer; Ref: reference allele; Alt: alternative allele; AA: amino acid; fs: frameshift; del: deletion; ins: insertion; INDEL: insertion/deletion; Met: methionine; Gly: glycine; Phe: phenylalanine; Ala: alanine; Ile: isoleucine; Arg: arginine; Pro: proline; Ter: termination; Asp: aspartic acid; Gln: glutamine; Ser: serine.